Afinum 9 takes majority stake in mymediset

mymediset is a tech provider for SAP-integrated medical device management in the health sector.

  • mymediset CEO Michael Knauer will hold a significant investment in the firm
  • This investment marks the sixth platform investment by Afinum 9 fund since October 2021
  • Afinum Management is an investment firm headquartered in Bavaria, Germany

Afinum 9 has acquired a majority stake in mymediset, a technology provider for SAP-integrated medical device management in the healthcare industry. No financial details of the transaction were disclosed.

mymediset provides fully SAP-integrated software and cloud-based apps for more efficient, responsible, and reliable medical device management.

The firm currently operates international subsidiaries in Boston, US, and Singapore. It is based in Freiburg, Germany and is in the process of opening two new offices in Cape Town, South Africa, and São Paulo, Brazil.

Afinum 9 will partner with founder and CEO Michael Knauer to drive and execute mymediset’s next growth phase, according to a release.

Knauer will have significant investment in mymediset.

This investment in mymediset is the sixth platform investment by Afinum 9 fund since October 2021.

Afinum Management is an investment firm headquartered in Bavaria, Germany.